Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This is a nationwide, multicenter and prospective cohort study. The purpose of this study is
to evaluate the synergistic effect and safety of Elemene plus TKIs in EGFR-mutated advanced
non-small cell lung cancer.